UniProt ID | ATAD1_HUMAN | |
---|---|---|
UniProt AC | Q8NBU5 | |
Protein Name | ATPase family AAA domain-containing protein 1 | |
Gene Name | ATAD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 361 | |
Subcellular Localization | Peroxisome . Cell junction, synapse, postsynaptic cell membrane . | |
Protein Description | ATPase that plays a critical role in regulating the surface expression of AMPA receptors (AMPAR), thereby regulating synaptic plasticity and learning and memory. Required for NMDA-stimulated AMPAR internalization and inhibition of GRIA1 and GRIA2 recycling back to the plasma membrane; these activities are ATPase-dependent (By similarity).. | |
Protein Sequence | MVHAEAFSRPLSRNEVVGLIFRLTIFGAVTYFTIKWMVDAIDPTRKQKVEAQKQAEKLMKQIGVKNVKLSEYEMSIAAHLVDPLNMHVTWSDIAGLDDVITDLKDTVILPIKKKHLFENSRLLQPPKGVLLYGPPGCGKTLIAKATAKEAGCRFINLQPSTLTDKWYGESQKLAAAVFSLAIKLQPSIIFIDEIDSFLRNRSSSDHEATAMMKAQFMSLWDGLDTDHSCQVIVMGATNRPQDLDSAIMRRMPTRFHINQPALKQREAILKLILKNENVDRHVDLLEVAQETDGFSGSDLKEMCRDAALLCVREYVNSTSEESHDEDEIRPVQQQDLHRAIEKMKKSKDAAFQNVLTHVCLD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Ubiquitination | -MVHAEAFSRPLSRN -CCCHHHCCCCCCHH | 4.85 | 27667366 | |
8 | Phosphorylation | MVHAEAFSRPLSRNE CCCHHHCCCCCCHHH | 39.78 | 21406692 | |
12 | Phosphorylation | EAFSRPLSRNEVVGL HHCCCCCCHHHHHHH | 35.42 | 21406692 | |
25 | Ubiquitination | GLIFRLTIFGAVTYF HHHHHHHHHCHHHHH | 3.38 | 32015554 | |
29 | Ubiquitination | RLTIFGAVTYFTIKW HHHHHCHHHHHHHHH | 4.57 | 29967540 | |
44 | Phosphorylation | MVDAIDPTRKQKVEA HHHCCCCCHHHHHHH | 46.91 | 20068231 | |
46 | Ubiquitination | DAIDPTRKQKVEAQK HCCCCCHHHHHHHHH | 57.88 | 22817900 | |
53 | "N6,N6-dimethyllysine" | KQKVEAQKQAEKLMK HHHHHHHHHHHHHHH | 59.53 | - | |
53 | Methylation | KQKVEAQKQAEKLMK HHHHHHHHHHHHHHH | 59.53 | - | |
54 | Ubiquitination | QKVEAQKQAEKLMKQ HHHHHHHHHHHHHHH | 42.55 | 21890473 | |
55 | Ubiquitination | KVEAQKQAEKLMKQI HHHHHHHHHHHHHHH | 23.95 | 22817900 | |
56 | Ubiquitination | VEAQKQAEKLMKQIG HHHHHHHHHHHHHHC | 44.20 | 22817900 | |
60 | Ubiquitination | KQAEKLMKQIGVKNV HHHHHHHHHHCCCCC | 49.56 | 29967540 | |
60 | Methylation | KQAEKLMKQIGVKNV HHHHHHHHHHCCCCC | 49.56 | - | |
60 | "N6,N6-dimethyllysine" | KQAEKLMKQIGVKNV HHHHHHHHHHCCCCC | 49.56 | - | |
65 | Ubiquitination | LMKQIGVKNVKLSEY HHHHHCCCCCCCCHH | 51.30 | 27667366 | |
65 | 2-Hydroxyisobutyrylation | LMKQIGVKNVKLSEY HHHHHCCCCCCCCHH | 51.30 | - | |
107 | Ubiquitination | ITDLKDTVILPIKKK HHHCCCCEEEEECHH | 6.41 | 22817900 | |
112 | 2-Hydroxyisobutyrylation | DTVILPIKKKHLFEN CCEEEEECHHHHHCC | 54.55 | - | |
112 (in isoform 1) | Ubiquitination | - | 54.55 | 21890473 | |
112 | Ubiquitination | DTVILPIKKKHLFEN CCEEEEECHHHHHCC | 54.55 | 22817900 | |
112 (in isoform 2) | Ubiquitination | - | 54.55 | 21890473 | |
113 | Ubiquitination | TVILPIKKKHLFENS CEEEEECHHHHHCCC | 46.26 | 22817900 | |
114 | Ubiquitination | VILPIKKKHLFENSR EEEEECHHHHHCCCC | 40.30 | 27667366 | |
114 | Acetylation | VILPIKKKHLFENSR EEEEECHHHHHCCCC | 40.30 | 19608861 | |
127 | Ubiquitination | SRLLQPPKGVLLYGP CCCCCCCCEEEEECC | 69.23 | 29967540 | |
132 | Phosphorylation | PPKGVLLYGPPGCGK CCCEEEEECCCCCCH | 24.35 | - | |
137 | S-nitrosylation | LLYGPPGCGKTLIAK EEECCCCCCHHHHHH | 6.61 | 21278135 | |
137 | S-nitrosocysteine | LLYGPPGCGKTLIAK EEECCCCCCHHHHHH | 6.61 | - | |
139 | Ubiquitination | YGPPGCGKTLIAKAT ECCCCCCHHHHHHHH | 44.21 | 29967540 | |
144 | Acetylation | CGKTLIAKATAKEAG CCHHHHHHHHHHHHC | 39.00 | 25953088 | |
144 | Ubiquitination | CGKTLIAKATAKEAG CCHHHHHHHHHHHHC | 39.00 | 27667366 | |
146 | Phosphorylation | KTLIAKATAKEAGCR HHHHHHHHHHHHCCE | 37.24 | 19413330 | |
148 | Ubiquitination | LIAKATAKEAGCRFI HHHHHHHHHHCCEEE | 43.68 | 29967540 | |
151 | Ubiquitination | KATAKEAGCRFINLQ HHHHHHHCCEEEECC | 12.29 | 33845483 | |
155 | Ubiquitination | KEAGCRFINLQPSTL HHHCCEEEECCCCCC | 2.32 | 27667366 | |
165 | Ubiquitination | QPSTLTDKWYGESQK CCCCCCCCCCCHHHH | 36.76 | 21906983 | |
165 (in isoform 2) | Ubiquitination | - | 36.76 | 21890473 | |
165 (in isoform 1) | Ubiquitination | - | 36.76 | 21890473 | |
165 | Acetylation | QPSTLTDKWYGESQK CCCCCCCCCCCHHHH | 36.76 | 26051181 | |
167 | Phosphorylation | STLTDKWYGESQKLA CCCCCCCCCHHHHHH | 19.43 | 26657352 | |
181 | Ubiquitination | AAAVFSLAIKLQPSI HHHHHHHHHHHCCEE | 8.82 | 21963094 | |
202 | Phosphorylation | DSFLRNRSSSDHEAT HHHHHCCCCCHHHHH | 37.43 | - | |
203 | Phosphorylation | SFLRNRSSSDHEATA HHHHCCCCCHHHHHH | 36.23 | 33259812 | |
204 | Phosphorylation | FLRNRSSSDHEATAM HHHCCCCCHHHHHHH | 44.21 | - | |
205 | Ubiquitination | LRNRSSSDHEATAMM HHCCCCCHHHHHHHH | 45.66 | 27667366 | |
209 | Phosphorylation | SSSDHEATAMMKAQF CCCHHHHHHHHHHHH | 16.46 | - | |
212 | Ubiquitination | DHEATAMMKAQFMSL HHHHHHHHHHHHHHH | 2.78 | 21890473 | |
216 | Ubiquitination | TAMMKAQFMSLWDGL HHHHHHHHHHHHCCC | 4.25 | 22817900 | |
228 | Ubiquitination | DGLDTDHSCQVIVMG CCCCCCCCCEEEEEC | 14.73 | 29967540 | |
240 | Ubiquitination | VMGATNRPQDLDSAI EECCCCCCCCHHHHH | 33.82 | 21890473 | |
242 | Ubiquitination | GATNRPQDLDSAIMR CCCCCCCCHHHHHHH | 55.94 | 21963094 | |
244 | Ubiquitination | TNRPQDLDSAIMRRM CCCCCCHHHHHHHHC | 44.29 | 22817900 | |
263 (in isoform 1) | Ubiquitination | - | 49.79 | 21890473 | |
263 (in isoform 2) | Ubiquitination | - | 49.79 | 21890473 | |
263 | 2-Hydroxyisobutyrylation | HINQPALKQREAILK CCCCHHHHHHHHHHH | 49.79 | - | |
263 | Ubiquitination | HINQPALKQREAILK CCCCHHHHHHHHHHH | 49.79 | 27667366 | |
270 (in isoform 1) | Ubiquitination | - | 27.63 | 21890473 | |
270 (in isoform 2) | Ubiquitination | - | 27.63 | 21890473 | |
270 | Ubiquitination | KQREAILKLILKNEN HHHHHHHHHHHHCCC | 27.63 | 21963094 | |
274 | Ubiquitination | AILKLILKNENVDRH HHHHHHHHCCCCHHH | 56.04 | 27667366 | |
274 | Acetylation | AILKLILKNENVDRH HHHHHHHHCCCCHHH | 56.04 | 19829937 | |
274 (in isoform 1) | Ubiquitination | - | 56.04 | 21890473 | |
280 | Methylation | LKNENVDRHVDLLEV HHCCCCHHHCHHHHH | 27.70 | - | |
292 | Phosphorylation | LEVAQETDGFSGSDL HHHHHHCCCCCHHHH | 56.22 | 33259812 | |
300 | Acetylation | GFSGSDLKEMCRDAA CCCHHHHHHHHHHHH | 48.68 | 26051181 | |
300 | Ubiquitination | GFSGSDLKEMCRDAA CCCHHHHHHHHHHHH | 48.68 | 21963094 | |
303 | Glutathionylation | GSDLKEMCRDAALLC HHHHHHHHHHHHHHH | 3.60 | 22555962 | |
314 | Phosphorylation | ALLCVREYVNSTSEE HHHHHHHHHHCCCCC | 8.38 | 29255136 | |
317 | Phosphorylation | CVREYVNSTSEESHD HHHHHHHCCCCCCCC | 24.22 | 23401153 | |
317 | Ubiquitination | CVREYVNSTSEESHD HHHHHHHCCCCCCCC | 24.22 | 29967540 | |
318 | Phosphorylation | VREYVNSTSEESHDE HHHHHHCCCCCCCCC | 34.65 | 29255136 | |
319 | Phosphorylation | REYVNSTSEESHDED HHHHHCCCCCCCCCC | 38.91 | 23401153 | |
322 | Phosphorylation | VNSTSEESHDEDEIR HHCCCCCCCCCCCCC | 31.99 | 29255136 | |
347 | Ubiquitination | IEKMKKSKDAAFQNV HHHHHHCHHHHHHHH | 61.33 | 29967540 | |
359 | Glutathionylation | QNVLTHVCLD----- HHHHHHHHCC----- | 2.48 | 22555962 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ATAD1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATAD1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATAD1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GOSR1_HUMAN | GOSR1 | physical | 24843043 | |
TPM2_HUMAN | TPM2 | physical | 28514442 | |
ANKS6_HUMAN | ANKS6 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-114, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-146, AND MASSSPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"The proteomic reactor facilitates the analysis of affinity-purifiedproteins by mass spectrometry: application for identifyingubiquitinated proteins in human cells."; Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M.,Haines D.S., Figeys D.; J. Proteome Res. 6:298-305(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-46, AND MASSSPECTROMETRY. |